Skip to content

Long-term effects and adverse events of polyetheretherketone versus titanium mesh materials in repairing skull defects: a prospective, single-center, non-randomized controlled, 2-year follow-up clinical trial protocol

Long-term effects and adverse events of polyetheretherketone versus titanium mesh materials in repairing skull defects: a prospective, single-center, non-randomized controlled, 2-year follow-up clinical trial protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043703
Enrollment
Unknown
Registered
2021-02-27
Start date
2021-08-01
Completion date
Unknown
Last updated
2021-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skull defect

Interventions

trial group:Polyetheretherketone (PEEK) material
control group:titanium mesh material

Sponsors

The Fourth Affiliated Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with traumatic brain injury who received decompressive craniectomy or intracerebral hemorrhage craniotomy to remove hematoma; 2. Patients who underwent cranioplasty for the first time 12 weeks after decompressive craniectomy; 3. Adult patients (aged >= 18 years old), regardless of gender; 4. Patients with unilateral skull defect; 5. Patients who signed informed consent.

Exclusion criteria

Exclusion criteria: 1. The patient's condition before cranioplasty was poor, such as sepsis and brain swelling; 2. Patients with uncontrolled intracranial infection or intracranial hematoma before cranioplasty; 3. Patients who had been operated on skull defect for many times in the past; 4. The patient is allergic to transplantation materials; 5. Patients with history of brain tumor; 6. Patients with history of epilepsy.

Design outcomes

Primary

MeasureTime frame
Rate of failure in skull repair at 24 months after surgery;

Secondary

MeasureTime frame
Rate of failure in skull repair at 6 and 12 months after surgery;The incidence of adverse events at 6, 12, and 24 months after surgery;Glasgow Outcome Scale (GOS) scores at 6, 12, and 24 months after surgery;Satisfaction score for body shaping at 6, 12, and 24 months after surgery;Head CT imaging at 6, 12, and 24 months after surgery;

Countries

China

Contacts

Public ContactFeng Zhang

The Fourth Affiliated Hospital of China Medical University

cmu4hzf@126.com+86 18900912295

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026